BAUSCH HEALTH AMERICAS, INC.
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Employees
- 3.1K
- Market Cap
- -
- Website
- http://www.bauschhealth.com
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2016-05-27
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 152
- Registration Number
- NCT02785159
- Locations
- πΊπΈ
Valeant Site 12, Encino, California, United States
πΊπΈValeant Site 11, Pinellas Park, Florida, United States
πΊπΈValeant Site 05, Plainfield, Indiana, United States
Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT02767947
- Locations
- π©π΄
Valeant Site 01, Santo Domingo, Dominican Republic
ππ³Valeant Site 02, San Pedro Sula, Honduras
π©π΄Valeant Site 03, San Cristobal, Dominican Republic
Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris
- First Posted Date
- 2016-05-10
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02767271
- Locations
- ππ³
Valeant Site 02, San Pedro Sula, Honduras
π©π΄Valeant Site 01, Santo Domingo, Dominican Republic
Long Term Safety Study of Plecanatide
- First Posted Date
- 2016-03-11
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 2272
- Registration Number
- NCT02706483
- Locations
- πΊπΈ
Synergy Research Site, Milwaukee, Wisconsin, United States
πΊπΈSynergy Research Site., Charlotte, North Carolina, United States
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2015-08-04
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 213
- Registration Number
- NCT02515097
- Locations
- πΊπΈ
Valeant Site 03, Houston, Texas, United States
πΊπΈValeant Site 09, San Antonio, Texas, United States
πΊπΈValeant Site 06, West Jordan, Utah, United States
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2015-08-03
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT02514577
- Locations
- πΊπΈ
Valeant Site 11, Hot Springs, Arkansas, United States
πΊπΈValeant Site 1, Encinitas, California, United States
πΊπΈValeant Site 12, Santa Rosa, California, United States
Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy
- Conditions
- Interventions
- First Posted Date
- 2015-07-27
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02508805
- Locations
- π·πΊ
State Autonomous Institution Republican Clinical Centre of Neurology, Kazan, Republic of Tatarstan, Russian Federation
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
- Conditions
- Interventions
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 1135
- Registration Number
- NCT02493452
- Locations
- πΊπΈ
Synergy Research Site, La Crosse, Wisconsin, United States
πΊπΈSynergy Research Site., Orlando, Florida, United States
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT02462070
- Locations
- πΊπΈ
Valeant Site 16, Denver, Colorado, United States
πΊπΈValeant Site 8, Louisville, Kentucky, United States
πΊπΈValeant Site 6, Nashville, Tennessee, United States
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 555
- Registration Number
- NCT02462083
- Locations
- πΊπΈ
Valeant Site 6, Mobile, Alabama, United States
πΊπΈValeant Site 43, Los Angeles, California, United States
πΊπΈValeant Site 44, Santa Monica, California, United States